Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionchitinase activity

CHIA CHI3L2 CHIT1

5.82e-0661343GO:0004568
GeneOntologyMolecularFunctionchitin binding

CHIA CHI3L2 CHIT1

1.61e-0581343GO:0008061
GeneOntologyMolecularFunctioncarbohydrate binding

DGCR2 CHIA CLEC5A POMGNT1 ADGRL1 CHI3L2 KLRK1 CD69 CRYBG3

2.50e-043101349GO:0030246
GeneOntologyMolecularFunctionligand-gated monoatomic cation channel activity

BEST2 CHRND ANO6 CNGB3 SCNN1A CNGA2

3.67e-041401346GO:0099094
GeneOntologyMolecularFunctionTRAIL binding

TNFSF10 TNFRSF10B

4.41e-0451342GO:0045569
GeneOntologyBiologicalProcesschitin catabolic process

CHIA CHI3L2 CHIT1

5.17e-0661333GO:0006032
GeneOntologyBiologicalProcesschitin metabolic process

CHIA CHI3L2 CHIT1

5.17e-0661333GO:0006030
GeneOntologyBiologicalProcessglucosamine-containing compound catabolic process

CHIA CHI3L2 CHIT1

2.14e-0591333GO:1901072
Domain-

CHIA CHI3L2 CHIT1

3.49e-06513333.10.50.10
DomainChitinase_insertion

CHIA CHI3L2 CHIT1

3.49e-0651333IPR029070
DomainGlyco_hydro_18_chit_AS

CHIA CHI3L2 CHIT1

6.95e-0661333IPR001579
DomainGlyco_hydro18_cat

CHIA CHI3L2 CHIT1

1.21e-0571333IPR001223
DomainGlyco_hydro_18

CHIA CHI3L2 CHIT1

1.21e-0571333PF00704
DomainChitinase_II

CHIA CHI3L2 CHIT1

1.21e-0571333IPR011583
DomainGlyco_18

CHIA CHI3L2 CHIT1

1.21e-0571333SM00636
DomainCHITINASE_18

CHIA CHI3L2 CHIT1

1.21e-0571333PS01095
DomainChitin-bd_dom

CHIA CHIT1

5.03e-0521332IPR002557
DomainCBM_14

CHIA CHIT1

5.03e-0521332PF01607
DomainCHIT_BIND_II

CHIA CHIT1

5.03e-0521332PS50940
Domain-

CHIA CHIT1

5.03e-05213322.170.140.10
DomainChtBD2

CHIA CHIT1

5.03e-0521332SM00494
DomainC-type_lectin-like/link

DGCR2 CLEC5A KLRK1 LYVE1 CD69

7.11e-04991335IPR016186
Pubmed

Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response.

LYVE1 CXCR4 CD69

2.11e-067138327841869
Pubmed

Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.

TNFSF10 TNFRSF10B

1.56e-052138223678861
Pubmed

Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5.

TNFSF10 TNFRSF10B

1.56e-052138231433987
Pubmed

Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis.

CHIA CHIT1

1.56e-052138235122869
Pubmed

The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.

TNFSF10 TNFRSF10B

1.56e-052138227176505
Pubmed

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

TNFSF10 TNFRSF10B

1.56e-052138212642868
Pubmed

The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor Pathway.

TNFSF10 TNFRSF10B

1.56e-052138230647121
Pubmed

Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development.

TNFSF10 TNFRSF10B

1.56e-052138215828026
Pubmed

Nlp promotes autophagy through facilitating the interaction of Rab7 and FYCO1.

FYCO1 RAB7A

1.56e-052138233859171
Pubmed

Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells.

TNFSF10 TNFRSF10B

1.56e-052138225882551
Pubmed

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.

TNFSF10 TNFRSF10B

1.56e-052138216731632
Pubmed

Chitinolytic activity in nasal polyps.

CHIA CHIT1

1.56e-052138221711963
Pubmed

Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin.

TNFSF10 TNFRSF10B

1.56e-052138226063410
Pubmed

ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.

TNFSF10 TNFRSF10B

1.56e-052138218599488
Pubmed

ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non-Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms.

TNFSF10 TNFRSF10B

1.56e-052138228424227
Pubmed

Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells.

TNFSF10 TNFRSF10B

1.56e-052138214691451
Pubmed

TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.

TNFSF10 TNFRSF10B

1.56e-052138222110611
Pubmed

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized.

TNFSF10 TNFRSF10B

1.56e-052138222496450
Pubmed

Ibuprofen enhances TRAIL-induced apoptosis through DR5 upregulation.

TNFSF10 TNFRSF10B

1.56e-052138224002210
Pubmed

Increased expression of acidic mammalian chitinase and chitotriosidase in the nasal mucosa of patients with allergic rhinitis.

CHIA CHIT1

1.56e-052138220422678
Pubmed

Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.

RAE1 KLRK1

1.56e-052138228739693
Pubmed

Identification and characterization of a new member of the TNF family that induces apoptosis.

TNFSF10 TNFRSF10B

1.56e-05213828777713
Pubmed

Occurrence and regional distribution of TRAIL and DR5 on temporomandibular joint discs: comparison of disc derangement with and without reduction.

TNFSF10 TNFRSF10B

1.56e-052138220123409
Pubmed

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

TNFSF10 TNFRSF10B

1.56e-052138210542098
Pubmed

Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer.

TNFSF10 TNFRSF10B

1.56e-052138220339295
Pubmed

Toll-like receptor 5 and 8 in hepatocellular carcinoma.

TLR8 TLR5

1.56e-052138233950532
Pubmed

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.

TNFSF10 TNFRSF10B

1.56e-052138215520016
Pubmed

Evaluation of AMCase and CHIT-1 expression in monocyte macrophages lineage.

CHIA CHIT1

1.56e-052138223129258
Pubmed

A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL).

TNFSF10 TNFRSF10B

1.56e-052138219674787
Pubmed

TRAIL or TRAIL-R2 as a Predictive Biomarker for Mortality or Cardiovascular Events: A Systematic Review and Meta-analysis.

TNFSF10 TNFRSF10B

1.56e-052138236888983
Pubmed

Identification of a novel acidic mammalian chitinase distinct from chitotriosidase.

CHIA CHIT1

1.56e-052138211085997
Pubmed

Aneurysmal bone cyst with an unusual clinical presentation and a novel VDR-USP6 fusion.

USP6 VDR

1.56e-052138234369017
Pubmed

Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.

TNFSF10 TNFRSF10B

1.56e-052138227740879
Pubmed

High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.

TNFSF10 TNFRSF10B

1.56e-052138227725224
Pubmed

Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.

TNFSF10 TNFRSF10B

1.56e-052138229048428
Pubmed

Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.

TNFSF10 TNFRSF10B

1.56e-052138223428290
Pubmed

NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells.

TNFSF10 KLRK1

1.56e-052138224019170
Pubmed

Specificity of molecular recognition learned from the crystal structures of TRAIL and the TRAIL:sDR5 complex.

TNFSF10 TNFRSF10B

1.56e-052138215110168
Pubmed

Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation.

TNFSF10 TNFRSF10B

1.56e-052138232722598
Pubmed

Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.

TNFSF10 TNFRSF10B

1.56e-052138231673231
Pubmed

Genetic association between human chitinases and lung function in COPD.

CHIA CHIT1

1.56e-052138222200767
Pubmed

Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis.

TNFSF10 TNFRSF10B

1.56e-052138218341587
Pubmed

Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance.

RAE1 KLRK1

1.56e-052138233279621
Pubmed

Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study.

TLR8 TLR5

1.56e-052138232854231
Pubmed

The release of soluble forms of TRAIL and DR5 by neutrophils of oral cavity cancer patients.

TNFSF10 TNFRSF10B

1.56e-052138218519235
Pubmed

CHIT1 and AMCase expression in human gastric mucosa: correlation with inflammation and Helicobacter pylori infection.

CHIA CHIT1

1.56e-052138219242357
Pubmed

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.

TNFSF10 TNFRSF10B

1.56e-052138226609227
Pubmed

Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway.

TNFSF10 TNFRSF10B

1.56e-052138227277541
Pubmed

The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells.

TNFSF10 TNFRSF10B

1.56e-052138226577955
Pubmed

Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines.

TNFSF10 TNFRSF10B

1.56e-052138215688023
Pubmed

Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.

TNFSF10 TNFRSF10B

1.56e-052138219412666
Pubmed

Human and mouse proteases: a comparative genomic approach.

OVCH2 PRSS38 USP29 USP6 USP42

1.84e-0581138512838346
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

ABCA13 DOCK10 FYCO1 YEATS2 POLQ SORL1 NLRP5

2.07e-05208138733230847
Pubmed

Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.

TNFSF10 TNFRSF10B

4.68e-053138223053497
Pubmed

Fungal exposure modulates the effect of polymorphisms of chitinases on emergency department visits and hospitalizations.

CHIA CHIT1

4.68e-053138220538957
Pubmed

[Effect of tumor necrosis factor-related apoptosis-inducing ligand on developing human oligodendrocytes in culture].

TNFSF10 TNFRSF10B

4.68e-053138225845236
Pubmed

Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.

RAE1 KLRK1

4.68e-053138211520456
Pubmed

Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.

TNFSF10 TNFRSF10B

4.68e-053138216226105
Pubmed

Caffeic acid phenethyl ester enhances TRAIL-mediated apoptosis via CHOP-induced death receptor 5 upregulation in hepatocarcinoma Hep3B cells.

TNFSF10 TNFRSF10B

4.68e-053138227260301
Pubmed

Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy.

TNFSF10 TNFRSF10B

4.68e-053138227612013
Pubmed

The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells.

TNFSF10 TNFRSF10B

4.68e-053138219212626
Pubmed

Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells.

TNFSF10 TNFRSF10B

4.68e-053138229777390
Pubmed

NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.

TNFSF10 KLRK1

4.68e-053138222449797
Pubmed

The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.

CHIA CHIT1

4.68e-053138219644363
Pubmed

Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells.

TNFSF10 TNFRSF10B

4.68e-053138226964637
Pubmed

Death receptor 5 is activated by fucosylation in colon cancer cells.

TNFSF10 TNFRSF10B

4.68e-053138230589515
Pubmed

Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission.

TNFSF10 TNFRSF10B

4.68e-053138232777260
Pubmed

TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study.

TNFSF10 TNFRSF10B

4.68e-053138220839416
Pubmed

Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks.

TNFSF10 TNFRSF10B

4.68e-053138219305384
Pubmed

[Mechanism of leukemia cell apoptosis induced by sodium butyrate activating TRAIL pathway].

TNFSF10 TNFRSF10B

4.68e-053138219379558
Pubmed

IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice.

RAE1 KLRK1

4.68e-053138225351459
Pubmed

Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

TNFSF10 TNFRSF10B

4.68e-053138221697087
Pubmed

Piceatannol enhances TRAIL-induced apoptosis in human leukemia THP-1 cells through Sp1- and ERK-dependent DR5 up-regulation.

TNFSF10 TNFRSF10B

4.68e-053138221167276
Pubmed

Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.

TNFSF10 TNFRSF10B

4.68e-053138221769428
Pubmed

TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes.

TNFSF10 TNFRSF10B

4.68e-053138231114586
Pubmed

The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway.

TNFSF10 TNFRSF10B

4.68e-053138226615420
Pubmed

Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist.

TNFSF10 TNFRSF10B

4.68e-053138234728311
Pubmed

Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.

KLRK1 CD69

4.68e-053138226100786
Pubmed

FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells.

TNFSF10 TNFRSF10B

4.68e-053138225843953
Pubmed

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

TNFSF10 TNFRSF10B

4.68e-053138217983809
Pubmed

Polymorphisms of chitinases are not associated with asthma.

CHIA CHIT1

4.68e-053138220226308
Pubmed

CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.

TNFSF10 TNFRSF10B

4.68e-053138230862357
Pubmed

Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis.

TNFSF10 TNFRSF10B

4.68e-053138220097879
Pubmed

NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis.

RAE1 KLRK1

4.68e-053138219177594
Pubmed

Induction of LYVE-1/stabilin-2-positive liver sinusoidal endothelial-like cells from embryoid bodies by modulation of adrenomedullin-RAMP2 signaling.

RAMP2 LYVE1

4.68e-053138221782867
Pubmed

Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.

TNFSF10 TNFRSF10B

4.68e-053138223615398
Pubmed

BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas.

TNFSF10 TNFRSF10B

4.68e-053138223579274
Pubmed

TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.

TNFSF10 TNFRSF10B

4.68e-053138219074831
Pubmed

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.

TNFSF10 TNFRSF10B

4.68e-053138212920112
Pubmed

Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5.

TNFSF10 TNFRSF10B

4.68e-053138228270124
Pubmed

TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5.

TNFSF10 TNFRSF10B

4.68e-053138220354842
Pubmed

Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.

CHIA CHIT1

4.68e-053138221159721
Pubmed

Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

RAE1 KLRK1

4.68e-053138221411527
Pubmed

Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.

RAE1 KLRK1

4.68e-053138220530257
Pubmed

Ancestry and pharmacogenetics of antileukemic drug toxicity.

CYP3A5 VDR

4.68e-053138217264302
Pubmed

FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport.

FYCO1 RAB7A

4.68e-053138220100911
Pubmed

Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.

TNFSF10 TNFRSF10B

4.68e-053138221279373
Pubmed

IgE- and FcepsilonRI-mediated enhancement of surface CD69 expression in basophils: role of low-level stimulation.

FCER1A CD69

4.68e-053138217541278
Pubmed

Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth.

CPA3 FCER1A

4.68e-053138231931959
Pubmed

Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.

TNFSF10 TNFRSF10B

4.68e-053138215655781
GeneFamilyChitinases

CHIA CHI3L2 CHIT1

6.93e-0671073816
GeneFamilyADAM metallopeptidase domain containing|CD molecules

TNFSF10 TNFRSF10B PTGFRN TLR8 KLRK1 CXCR4 CD69 ACKR1 CD300E

5.53e-043941079471
GeneFamilyZinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors

FYCO1 ZFYVE26 WDFY1

8.03e-0431107381
GeneFamilyExocyst complex

EXOC8 EXOC6B

1.22e-03910721055
GeneFamilyCyclic nucleotide gated channels

CNGB3 CNGA2

1.51e-03101072250
GeneFamilyCD molecules|Toll like receptors

TLR8 TLR5

1.51e-03101072948
GeneFamilyApolipoprotein B mRNA editing enzyme catalytic subunits

APOBEC3D APOBEC4

2.20e-03121072406
GeneFamilyATAC complex

YEATS2 KAT2B

2.59e-031310721058
GeneFamilyUbiquitin specific peptidases

USP29 USP6 USP42

4.45e-03561073366
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

F13B CSMD1 GABBR1

4.68e-035710731179
CoexpressionGSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP

ABR SYN3 ADGRL1 MAPKAPK5 HHLA1 STIM1 CXCR4 TLR5

1.14e-052001388M5241
CoexpressionGSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN

TMEM67 DOCK10 DNAJC22 CHIT1 SERPINB11 UBASH3B GABBR1

1.27e-051461387M6341
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAMP2 SYN3 DSCAM PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

1.27e-0718414081a4297b9d3cc4744bea0408fd5ee7b33ba2a1d78
ToppCellCOVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type

DSCAM ABCA13 DOCK10 CXCR4 SKAP1 CD69 CSMD1 SORL1

1.62e-071901408e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

1.75e-071921408fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3
ToppCell5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

1.75e-0719214084e63d95f75fe6eb3f817e84528883e95093c5bbd
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 ABCA13 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A SORL1

1.98e-0719514082a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABR KLRK1 YEATS2 CD300LD SERPINB11 RP2 ACKR1

5.39e-07152140787a7116d0064a6051bdf28ce1e48bfc168273e66
ToppCellPosterior_cortex-Hematopoietic-MACROPHAGE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

PKHD1L1 TLR8 LYVE1 CD300LD NEK5 TLR5

8.59e-07102140657ad3d48adeb41f6ab65883e61d3b1e74a94ad1a
ToppCellPosterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

PKHD1L1 TLR8 LYVE1 CD300LD NEK5 TLR5

8.59e-0710214069392288e284b71f3a208d9f283e6e3c944b7dd10
ToppCellPosterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

PKHD1L1 TLR8 LYVE1 CD300LD NEK5 TLR5

8.59e-0710214060ec549ee94da5f2d7275490e90d816c645f6d4fc
ToppCellPosterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

PKHD1L1 TLR8 LYVE1 CD300LD NEK5 TLR5

8.59e-07102140630fa92383898f370dabc41dd23d6907f14ba1a06
ToppCellPosterior_cortex-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

PKHD1L1 TLR8 LYVE1 CD300LD NEK5 TLR5

8.59e-071021406c58e09aaa11b664c7d99e91f903561fa18460f05
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAMP2 TNFSF10 PRSS23 F13B LYVE1 CTHRC1 ACKR1

1.10e-0616914078dba7546adc6b1345933eec81fc77fc9611fae60
ToppCellfacs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAMP2 TNFSF10 PRSS23 F13B LYVE1 CTHRC1 ACKR1

1.10e-061691407d2862a7ddee6d7a65d84ef9d0800ba6f4690973f
ToppCellE12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SGSM1 RAMP2 SYN3 PTGFR YEATS2 LYVE1 PLEKHM3

1.24e-0617214073b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TLR8 KLRK1 CXCR4 SCNN1A CD69 SCIN KYNU

1.29e-061731407c63a615998d13b1725b5767f4ad2ec7e2b61db68
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 SLC19A3 PRSS23 PKHD1L1 LYVE1 ZDHHC15 DCP1A

1.39e-06175140709163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCellfacs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 SLC19A3 PRSS23 PKHD1L1 LYVE1 ZDHHC15 DCP1A

1.39e-0617514070801cccec6915aefc135262fc74580280fd51aa5
ToppCellThalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32

CPA3 TLR8 LYVE1 CD300LD FCER1A TLR5

1.41e-061111406a1b7940c6fa0e5a58aa4798b604469d79f33fa44
ToppCellThalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32

CPA3 TLR8 LYVE1 CD300LD FCER1A TLR5

1.41e-061111406fd7aa25e83a0d762969e3966a658652da40c490e
ToppCellThalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32

CPA3 TLR8 LYVE1 CD300LD FCER1A TLR5

1.41e-061111406d1ec8e8e9adb11511b4ef363cc6f99286e2cc842
ToppCellThalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32

CPA3 TLR8 LYVE1 CD300LD FCER1A TLR5

1.41e-061111406567e5ac2c78d45db207067f0f152bb24ed048c50
ToppCellThalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32

CPA3 TLR8 LYVE1 CD300LD FCER1A TLR5

1.41e-061111406d48561078c387ac856c1c30e3d7a3e75ebde942e
ToppCell3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

1.61e-0617914071c0c0647a111f691dae55f4ed8c51006059ce020
ToppCell5'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 TNFSF10 PRSS23 LYVE1 CD69 TM4SF18 IPO11

2.32e-061891407a34f008dfcee4012977bbc5b60de6f0329ca2f65
ToppCellnormal_Lung-Endothelial_cells-Lymphatic_ECs|normal_Lung / Location, Cell class and cell subclass

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.40e-0619014072185db6007404a2b22325f91460dd17635be9bba
ToppCellwk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.48e-061911407631f95fd80dd3678b5b2ef201abf7fe646049af6
ToppCellPCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

TNFSF10 ZNF366 LYVE1 CXCR4 CTHRC1 CD69 TM4SF18

2.66e-061931407d338a7c0585b69947c37f44aa0381619493e31ea
ToppCellRA-08._Macrophage|World / Chamber and Cluster_Paper

ABR TRPS1 DOCK10 LYVE1 UBASH3B CD300E KYNU

2.66e-0619314075fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCellwk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.75e-061941407bc03d0f8dca9f4ba10db2f2274293f8b119e8951
ToppCellControl-Endothelial|Control / Disease state, Lineage and Cell class

RAMP2 SYN3 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

2.75e-061941407485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCellASK440-Endothelial-Lymphatic|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.75e-0619414074aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A SORL1

2.85e-061951407576142b4e75457c0973051bccc4163bd624496af
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A SORL1

2.85e-0619514078f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCellASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

2.85e-0619514071cdaab17866a1e5170e0f6bfcc69134425fdd8df
ToppCellBronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A SORL1

2.95e-061961407057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 ABCA13 PRSS23 PTGFR SERPINB11 SCNN1A ATP12A

2.95e-061961407c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A SORL1

2.95e-0619614078e909c31733762646359fe78b645cbd60237459e
ToppCellwk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.95e-061961407ff627244d7f5fd6a2ec009dae32d3509f0e2d95e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SOX6 TNFSF10 MFHAS1 RALGPS2 SKAP1 SCNN1A SCIN

3.05e-0619714077e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell3'-Child09-12-SmallIntestine-Endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 PRSS23 LYVE1 CTHRC1 TM4SF18 ACKR1 IPO11

3.05e-06197140786a02fd7b4762b3278e5e60b5483b5fc1206e597
ToppCellParenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

RAMP2 TNFSF10 PRSS23 LYVE1 BTNL3 TM4SF18 ACKR1

3.26e-061991407edb68a4f622a494f22fd7b25bc40ae0d58456cdb
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RAMP2 TNFSF10 PRSS23 LYVE1 BTNL3 TM4SF18 ACKR1

3.26e-06199140745f9c03d2ed2d98d66086fb0251bd24e30c6f775
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

RAMP2 TNFSF10 PRSS23 LYVE1 BTNL3 TM4SF18 ACKR1

3.26e-061991407448dd5a27d57627468c6b8347f1b6b1005aea004
ToppCellBiopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

CFAP47 ABCA13 DNAJC22 APOBEC4 PITX1 TEKT4 ATP12A

3.37e-062001407a552a99f5e4fa00dfb7775e5a3e1f62f1530d104
ToppCellLung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

3.37e-06200140741ac6adbf61763aa8a81a0ed586c4a5542a42cc5
ToppCellLung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

3.37e-0620014075109b417c066ecca0252008206b4f4b7a14c8702
ToppCellParenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

3.37e-0620014079e5627e11288713aa9b622aae40e849dd6eacd29
ToppCellBiopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type

RAMP2 TNFSF10 PRSS23 PKHD1L1 LYVE1 TM4SF18 ACKR1

3.37e-0620014077ccd3b617838b39da814278dc0e12384013401ce
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SOX6 OVCH2 RAMP2 SLC6A16 CXCR4 SPON1

5.66e-061411406ad9a25569c142fb68ded34aeba0cd9be8124ce56
ToppCellfacs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTTG1IP2 ABCA13 BEST2 USP29 CNGB3 ATP12A

6.64e-06145140696712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCellRV-17._Lymphocyte|RV / Chamber and Cluster_Paper

APOBEC3D DOCK10 CPA3 SKAP1 CD69 SORL1

9.04e-061531406e1ea621184014415870e00d511386b8cc3e0833b
ToppCellCOVID-19-kidney-Mito-rich_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK10 F13B CXCR4 SKAP1 CD69 SORL1

9.38e-061541406b437acc11e35fe05389e552d507f6f76e20cc102
ToppCellfacs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD300LD CXCR4 SCNN1A PLEKHM3 CD300E SORL1

1.05e-0515714060ad242320ada7bcb9e29548d3050bf4fd3a07115
ToppCellfacs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD300LD CXCR4 SCNN1A PLEKHM3 CD300E SORL1

1.05e-051571406fe4c9556806203e57522d1986754ebe5a20aa2de
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABR DOCK10 ANO6 RP2 CD300E GABBR1

1.05e-051571406ec433d2fe827abdb647be4176c231b7052482b6f
ToppCellPND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CHIA SLC19A3 APOBEC4 NEK5 SCNN1A CNGA2

1.17e-0516014061f4ee446436726c3d373f56d87dd80b6a12e8b9e
ToppCellPND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CHIA SLC19A3 APOBEC4 NEK5 SCNN1A CNGA2

1.17e-051601406028b5261a1da832d52f66fb620db83e5fbbd874a
ToppCellfacs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC5A TLR8 CD300LD SCNN1A CD300E SORL1

1.17e-051601406bd5fa7959bfe81011b8d798535b73ea1eee008b3
ToppCellDendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

ZNF366 CLEC5A FCER1A CXCR4 CD300E KYNU

1.30e-0516314065fff3932c1c259010e3add7a3b2301df2fa37df1
ToppCellfacs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SYNDIG1L OVCH2 RALGPS2 CD69 RP2 KYNU

1.34e-0516414064274a4f225cabf61f0fe27d8ea162b4eba612f87
ToppCellfacs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SYNDIG1L OVCH2 RALGPS2 CD69 RP2 KYNU

1.34e-051641406d62143450f59097ad4b34603a6257f897a769ead
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A

1.49e-05167140631633899aae852873a4887e72c621474b0a51a33
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RAMP2 PRSS23 LYVE1 CTHRC1 CRYBG3 RSPH10B

1.54e-05168140632e4d82efaccf336d347e4063253c3635a3ec672
ToppCellEndothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

RAMP2 PRSS23 PKHD1L1 LYVE1 CTHRC1 TM4SF18

1.59e-05169140695c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCellLPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 KLRK1 CXCR4 SKAP1 CD69 SORL1

1.70e-051711406539ea88acc6f948efdeae8b69e5c5ffaee29f1d9
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TNFSF10 MFHAS1 CPA3 CXCR4 SKAP1 CD69

1.70e-051711406e6dfbd2652b67577c8834c05348f62150637f348
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TNFSF10 MFHAS1 CPA3 CXCR4 SKAP1 CD69

1.70e-051711406ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41
ToppCellLPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 KLRK1 CXCR4 SKAP1 CD69 SORL1

1.76e-0517214060fc692be845d4225ff8b63bf9195724fc8510c2c
ToppCellfacs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSCAM ZNF366 CXCR4 PLEKHM3 SCIN KYNU

1.76e-051721406438d2e7f1897668a14d85ca70722e5d0102606dc
ToppCellfacs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSCAM ZNF366 CXCR4 PLEKHM3 SCIN KYNU

1.76e-051721406356a66cd9303470e427005cc67fdd22a2c4bf971
ToppCellfacs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DSCAM ZNF366 CXCR4 PLEKHM3 SCIN KYNU

1.76e-05172140646fadeee483fdf8402df92ec98575a09c6c15b16
ToppCellTCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9

APOBEC4 RSPH10B2 SERPINB11 PIP ATP12A SCIN

1.76e-0517214066b8a8d3b97c10b9d092307eed3cacbd2745df185
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A

1.82e-051731406e8afef5ae68983eb8d6515b43952636a47e9d3d4
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TNFSF10 FOLR1 PRSS23 PTGFR SERPINB11 ATP12A

1.82e-0517314063aa1d28d4814798a772808ed29e1dbbdf92abd03
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SYNDIG1L FOLR1 CHI3L2 MDN1 SCNN1A ATP12A

1.94e-051751406dbd9dac129fb6ae5f55e7b96d04b37585458dc4a
ToppCell10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

TNFSF10 CPA3 USP6 FCER1A CXCR4 CD69

1.94e-051751406ba1befc4e5f0167452f9ceace39377d16136dfa9
ToppCellEndothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

RAMP2 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.00e-051761406b288116a4588a1f9db9d49af92cea118937c9201
ToppCellnormal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass

RAMP2 TNFSF10 ZNF366 LYVE1 TM4SF18 ACKR1

2.00e-05176140671d1bd425772d89d8c550b909e0ec0e36ff22a7e
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 PKHD1L1 LYVE1 CTHRC1 TM4SF18 IPO11

2.07e-051771406b1775e05c28883a15c56628028770bc59d3233fb
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TNFSF10 CHI3L2 CXCR4 SKAP1 CD69 KYNU

2.07e-0517714069828504591599619649d41a78daf7c052729c669
ToppCellfacs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RALGPS2 DMXL1 CXCR4 CD69 KYNU SORL1

2.13e-0517814065b6f7e8a930c239db1f31edfb61b2b9228d28663
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.13e-051781406ccd37575b60102f5e647c01546e8ff8fec638bd7
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.13e-05178140687b04753650e45f12299c8456fb980d6c0d5961c
ToppCell5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAMP2 ZNF366 PRSS23 TM4SF18 ACKR1 IPO11

2.13e-051781406aa44851653d276226b922ee14dd1fc8d1a844cdf
ToppCellLA-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK10 CPA3 CXCR4 SKAP1 CD69 SORL1

2.13e-05178140634ec499d03cc198cfefa19a724d4c81974052f65
ToppCellfacs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.13e-051781406ebfae386a518ea33911ba3ff40464c94d18ef695
ToppCellControl-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 CHI3L2 CXCR4 SKAP1 CD69 SORL1

2.13e-051781406910f8bea19d335455aba24e6a07b4834b709db5d
ToppCellfacs-Heart-RA-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYNDIG1L CPA3 KLRK1 CXCR4 SKAP1 CD69

2.13e-051781406ba6ded4455233635a11afcf6f522c786bd81b5e0
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 KLRK1 SKAP1 CD69 UBASH3B SORL1

2.20e-051791406de3ddc1264e43727be50d69b81cc84a3c91812a2
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 KLRK1 SKAP1 CD69 UBASH3B SORL1

2.20e-051791406def981e97e3ff9019910c9af3861ca0d08eb0d0f
ToppCellControl-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DOCK10 CHI3L2 CXCR4 SKAP1 CD69 SORL1

2.20e-051791406d892d9496f1c33e23312092591eb2e968e736f7d
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CHI3L2 CXCR4 SKAP1 SCNN1A CD69 ADGRF3

2.27e-051801406702673c0b7c5b0d22a6af3884374804b8c4d6254
ToppCellfacs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.27e-051801406178648429686e6d4e6f3aafc350130e819788ecf
ToppCellfacs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.27e-051801406c2a8f61c806f6f6f47743e9f7c9700705db43386
ToppCell3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RAMP2 SYN3 TNFSF10 ZNF366 LYVE1 TM4SF18

2.27e-051801406be9d99a2e22e63824fb2a91974379da45160ae43
ToppCellfacs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.27e-051801406fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2
ToppCellfacs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.34e-05181140672c28baf4fd417ff4a7068603830d55074960144
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DSCAM RALGPS2 DOCK10 SKAP1 CRYBG3 SCIN

2.34e-05181140630729f0364f719c044712a51453e22dc2c1a232b
ToppCellfacs-Lung-3m-Endothelial-venous_endothelial-vein_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.34e-0518114062ac4d3e8987d5a009d7908d8787e18165826202a
ToppCellfacs-Lung-3m-Endothelial-venous_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RAMP2 TNFSF10 PRSS23 LYVE1 CTHRC1 ACKR1

2.34e-0518114062628c7ac345eaaeecf8e34617e81948925962cb9
DrugNalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A

TNFSF10 CYP3A5 MFHAS1 CPA3 CHI3L2 PIP CNGB3 PITX1 DEPDC5

2.82e-0619613693668_UP
DrugButacaine [149-16-6]; Up 200; 13uM; PC3; HT_HG-U133A

SLC6A16 DOCK10 DNAJC22 ELSPBP1 TGM4 CXCR4 SPON1 EXOC6B KYNU

3.20e-0619913695748_UP
Drugtri-N-acetylchitotriose

CHIA LYZL4 CHIT1

1.71e-0591363CID000123774
DrugAmidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A

DGCR2 CYP3A5 BEST2 TLR8 LYVE1 BTNL3 CNGB3 EXOC6B

2.49e-0519713682222_UP
DrugHydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A

DCAF1 SYN3 TBC1D30 TNFSF10 CYP3A5 DOCK10 CXCR4 KYNU

2.58e-0519813686651_UP
DrugPiromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A

DCAF1 SYN3 SLC6A16 CYP3A5 BEST2 DOCK10 PTGFR PIP

2.58e-0519813684398_UP
DrugTiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A

SYN3 TBC1D30 SLC6A16 USP29 DNAJC22 HHLA1 CNGB3 SCNN1A

2.58e-0519813683663_UP
DrugMetronidazole [443-48-1]; Down 200; 23.4uM; PC3; HT_HG-U133A

TNFSF10 CHI3L2 ELSPBP1 CNGB3 PITX1 EXOC6B KYNU VDR

2.58e-0519813684023_DN
Drugchi2 6

CHIA CHIT1

3.54e-0521362CID000063339
Druglaminarihexaose

CHIA CHIT1

3.54e-0521362CID000169096
DrugCID5289292

CHIA CHIT1

3.54e-0521362CID005289292
Drugglucoallosamidin B

CHIA CHIT1

3.54e-0521362CID000195827
DrugGlcNAc)8

CHIA CHIT1

3.54e-0521362CID000192495
Diseasecorneodesmosin measurement

TRPS1 ACKR1

6.90e-0491312EFO_0801499
DiseaseSchizophrenia and related disorders

SYN3 CYP3A5

6.90e-0491312C0809983
Diseasemonocyte count

TNFSF10 ZNF366 TRPS1 DOCK10 TNFRSF10B PTGFRN TMEM87A TLR8 LYVE1 CXCR4 TLR5 RAB7A UBASH3B ACKR1 SORL1

7.85e-04132013115EFO_0005091
Diseaseadseverin measurement

DNMBP SCIN

8.60e-04101312EFO_0801358
Diseaseabdominal obesity-metabolic syndrome (implicated_via_orthology)

SLC2A9 GUCY2C

8.60e-04101312DOID:0060611 (implicated_via_orthology)
DiseaseBarrett's esophagus (is_implicated_in)

CTHRC1 VDR

1.05e-03111312DOID:9206 (is_implicated_in)
Diseasetriacylglycerol 44:1 measurement

DSCAM CSMD1

1.25e-03121312EFO_0010399
DiseaseAlzheimer's disease biomarker measurement

SYN3 RASGEF1C SORL1

1.28e-03481313EFO_0006514
Diseaseneutrophil-to-lymphocyte ratio

CYP3A5 CD69 UBASH3B ACKR1 KYNU

1.44e-031851315EFO_0008447
Diseasemonocyte percentage of leukocytes

TNFSF10 TRPS1 DOCK10 TNFRSF10B CXCR4 TLR5 CD69 UBASH3B ACKR1 CD300E

1.61e-0373113110EFO_0007989
DiseaseDrug habituation

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0013170
DiseaseDrug abuse

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0013146
DiseasePrescription Drug Abuse

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C4316881
DiseaseSubstance-Related Disorders

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0236969
DiseaseDrug Use Disorders

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0013222
DiseaseDrug Dependence

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C1510472
DiseaseSubstance Dependence

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0038580
DiseaseSubstance Use Disorders

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0038586
DiseaseOrganic Mental Disorders, Substance-Induced

DSCAM ZNF366 ZNF606 CSMD1

1.75e-031151314C0029231
DiseaseSubstance abuse problem

DSCAM ZNF366 ZNF606 CSMD1

1.81e-031161314C0740858
DiseaseYKL40 measurement

LINC02898 CHIT1

1.98e-03151312EFO_0004869
DiseaseCongenital total cataract

FYCO1 DNMBP

2.25e-03161312C0266539
Diseaseneutrophil collagenase measurement

ABCA13 DNMBP

2.25e-03161312EFO_0008248
Diseaseforced expiratory volume

SYNDIG1L DSCAM MFHAS1 LINC02898 RALGPS2 PRSS23 PTGFR CXCR4 SKAP1 RASGEF1C

2.79e-0378913110EFO_0004314
Diseasetuberculosis

OVCH2 DSCAM DCUN1D5 SPON1 CSMD1

2.83e-032161315MONDO_0018076
DiseaseMalignant neoplasm of breast

TNFSF10 ZNF366 DNAJC21 CHRND CXCR4 SMARCD1 ZFYVE26 TEKT4 CNGA2 NIPBL SORL1 VDR

3.05e-03107413112C0006142
Diseaseosteoporosis (implicated_via_orthology)

ATP6V1H VDR

3.18e-03191312DOID:11476 (implicated_via_orthology)
Diseasemetabolite measurement

CLTCL1 SLC2A9 SYN3 DSCAM CYP3A5 CSMD1 DNMBP SORL1

3.62e-035601318EFO_0004725
Diseaseosteoarthritis (biomarker_via_orthology)

TNFSF10 TNFRSF10B

3.89e-03211312DOID:8398 (biomarker_via_orthology)
Diseasesystemising measurement

DSCAM CNGA2

3.89e-03211312EFO_0010221

Protein segments in the cluster

PeptideGeneStartEntry
WTCGNQDYKYRVSDV

VDR

286

P11473
TSAGKHQQYDCKWYI

ABR

336

Q12979
SGTYYCTGKVWQLDY

FCER1A

171

P12319
TYFPFDWQNCSLKFS

CHRND

156

Q07001
FENLNSSYNKYWVPC

BEST2

171

Q8NFU1
LYGCWFSSQIYDEEA

BTNL3

111

Q6UXE8
NFYCACLSGYQWNTS

ADGRF3

176

Q8IZF5
YFWDTDYQEGLCSLS

APOBEC3D

321

Q96AK3
TVQCAYGSGWETYLK

CD300LD

36

Q6UXZ3
VDAVANWYFGNFLCK

CXCR4

96

P61073
LFSSSVIYACWEGYK

CSMD1

2996

Q96PZ7
YKQCSWSSLNYGIDL

CTHRC1

106

Q96CG8
WVAYQQKFFCGEQYI

CRYBG3

2616

Q68DQ2
SGKNTQIWYYCRGLF

CRYBG3

2871

Q68DQ2
LSYRQGLWKFDTECY

CYP3A5

51

P20815
VKPYYWLSFSLDCSN

APOBEC4

16

Q8WW27
NCSFWNYSERSMLGY

ADGRL1

801

O94910
NKYWCRGQYDTSCES

CD300E

46

Q496F6
WAYYEICTFLKNGAT

CHIA

301

Q9BZP6
FDSSLYFLCGWYLSN

ABCA13

3761

Q86UQ4
LGYCVWYGSAFAQAL

ACKR1

131

Q16570
KSLYNEWGCTNYINL

DNMBP

901

Q6XZF7
AYKLVCYFTNWSQDR

CHI3L2

26

Q15782
SLSIYSIWFYDKNDC

DCP1A

101

Q9NPI6
DADGYLSLYQTNWKC

DMXL1

2806

Q9Y485
FSSKKCLAWFYEYAG

DCUN1D5

46

Q9BTE7
NGNIFAYASSYDWSK

RAE1

326

P78406
KYKGNDYSQYSPWSC

RC3H1

801

Q5TC82
YETAVQFCWNHYKDQ

RAMP2

61

O60895
KLYVLCESQSGYVWN

PGBD4

276

Q96DM1
AWCYSKNNIPYFETS

RAB7A

141

P51149
DCFWYLNALEASVSY

GUCY2C

201

P25092
LYGYLNQDNCTWSKE

ANO6

321

Q4KMQ2
SEDWVGYQRKCYFIS

CD69

86

Q07108
AAKLVCYFTNWAQYR

CHIT1

21

Q13231
TCYWENLLSEYSKFL

POGLUT1

356

Q8NBL1
KGSIYYNQEGTCWYE

RSPH10B

191

P0C881
KGSIYYNQEGTCWYE

RSPH10B2

191

B2RC85
YKWNYLDQYICSAGS

DEPDC5

916

O75140
IACNWKTYYARNDTV

DCAF1

606

Q9Y4B6
SSSWDGCQKYFYRSL

MDN1

4186

Q9NU22
WKVPVSRQFAAYCYN

LYVE1

116

Q9Y5Y7
GYSLENWVCLAYFES

LYZL4

41

Q96KX0
YTYNKSCDLWSLGVI

MAPKAPK5

216

Q8IW41
LNGSTAWYKFPCYVQ

MFHAS1

841

Q9Y4C4
SGYKENYTRWLCYCN

KAT2B

276

Q92831
ATLLGNKKDYWDYFC

FYCO1

61

Q9BQS8
YADNWFKIYDPSINC

GABBR1

396

Q9UBS5
CWIAYGIQYSSDKSA

ATP12A

126

P54707
YDLASGIYNFACSLW

IPO11

171

Q9UI26
CKASGYTFTSYDINW

IGHV1-8

41

P0DP01
YLSGSDLIQCYNFGW

F13B

246

P05160
DYKIQASRTWCFYNT

PTGFR

176

P43088
YNNKTDIWSLGCVLY

NEK5

181

Q6P3R8
KNWICYKNNCYQFFD

KLRK1

101

P26718
YKNNCYQFFDESKNW

KLRK1

106

P26718
VWACFNRYYGAISKL

NIPBL

2106

Q6KC79
KSLTFSSYGLQWCLY

NLRP5

56

P59047
DWSTYLADYGQPNCK

EXOC6B

741

Q9Y2D4
GKAKVCNYSGWYYCS

PLEKHM3

526

Q6ZWE6
GVYASVSYFSKWICD

PRSS38

276

A1L453
FYAYWQSFCTQKNFA

DNAJC21

151

Q5F1R6
FEQYTGDDCWVNLSY

EXOC8

601

Q8IYI6
YFGCRFSSIYWLNCK

PTTG1IP2

81

P0DTF9
CQWFVYQATKTYGRN

CPA3

186

P15088
EACKFYSSQWHVVNY

DOCK10

111

Q96BY6
CWGGRDAYYFSLQKE

POLQ

1906

O75417
IVYLCSYFWNSSKGV

LINC02898

111

Q6ZV80
VYLSGENYWDAAQTC

DGCR2

131

P98153
SKENLVWCATSYNYD

ELSPBP1

201

Q96BH3
CYQLCGLNAIWFYTN

SLC2A9

326

Q9NRM0
YQGNLWLLDYCQESY

KRTAP24-1

51

Q3LI83
CSSALGLYQWDFASY

FBXW2

341

Q9UKT8
GFNSSCFQEWAKLYE

DNAJC22

251

Q8N4W6
TANIWACYAGYLIFK

SLC19A3

366

Q9BZV2
SSWGYCYYKLQVDFS

SCNN1A

451

P37088
YCTQFTEWKFYLSGV

CFAP47

2726

Q6ZTR5
KDVSYLYRFNWNHCG

FOLR1

76

P15328
WTKYWAALCGTQLFY

RALGPS2

481

Q86X27
FAKYLQSSAAACWVY

TMEM67

226

Q5HYA8
YYSCIANNNWGSDEI

DSCAM

1356

O60469
QDFGNYYCSVTPWVK

PTGFRN

786

Q9P2B2
AAGYSYNNWAAKSLA

PITX1

176

P78337
SWSCQEKLYSYLLGG

SYNDIG1L

31

A6NDD5
YSVYNFCSKPWVFSQ

SYN3

196

O14994
YSWFLKNATYICQRV

HHLA1

496

C9JL84
ACGTAKYRLTFYGNW

SPON1

201

Q9HCB6
DAYAQYLWITFDFCN

SORL1

181

Q92673
FFDYARCSKNTAWPY

ATP6V1H

111

Q9UI12
YLWLNSGGCSFAAIY

SLC6A16

131

Q9GZN6
NLIKNDSGFYYCATW

TRGV1

101

A0A0A0MS02
WAQEAVCRYFYSKVQ

SMARCD1

486

Q96GM5
GTEIYQWCGSSCNKY

SCIN

171

Q9Y6U3
LNYPENYSDKANCDW

OVCH2

446

Q7RTZ1
DDSLYCISAWNDQGY

POMGNT1

416

Q8WZA1
YAQICYWIKGNYLDC

PRSS23

366

O95084
LLWNVYGDCDNYATL

SNRNP40

91

Q96DI7
TSKYLLEEWFQNCYA

TEKT4

36

Q8WW24
YYNTKQAVCFGQCWV

TGM4

256

P49221
AFHQQYLSCSEKWYQ

SERPINB11

116

Q96P15
CDDNPKTFYWDFYTN

PIP

91

P12273
GCWFAYIQNRYSKEH

STIM1

226

Q13586
WDNKAQYLLSCTGFA

SLC6A18

21

Q96N87
AMNGSAAKLQQYYCW

SOX6

581

P35712
EFRCIAAYLYKGNNW

CLTCL1

1506

P53675
SYGTVCPKDWEFYQA

CLEC5A

66

Q9NY25
RACFSDLQKGYYLVW

CNGA2

161

Q16280
INACVYYWASNYEGI

CNGB3

366

Q9NQW8
YLAWNCYFNKVCEKT

TLR8

176

Q9NR97
NGTEATSYYWCKFCS

TRPS1

426

Q9UHF7
QFNYCFDVDWLVKQY

TDP1

201

Q9NUW8
HYFCYIKASNGLWYQ

USP42

371

Q9H9J4
YDECQTKYGNANAWR

PPP6C

126

O00743
NKLTNYVWYFEGICF

TM4SF18

41

Q96CE8
SNLEAYVKWFNRLCY

RASGEF1C

246

Q8N431
DIYQNCCEAFGWNTY

TKTL2

201

Q9H0I9
SNIKFGCFQWYYPEL

RP2

141

O75695
YDFQKQAWFTYNDLC

USP29

846

Q9HBJ7
LAYARWNKTVGYCQG

TBC1D30

326

Q9Y2I9
SCKYGQDYSTHWNDL

TNFRSF10B

96

O14763
KWCNSGSQEEGYSQY

THOC7

36

Q6I9Y2
NFAYGNNWTYTCIDL

PKHD1L1

781

Q86WI1
CDRNYWYFTPANLEK

SGSM1

946

Q2NKQ1
SYYVDVGGSQKRWQC

ZNF366

241

Q8N895
FYKCEAYGRAFNWSS

ZNF117

136

Q03924
LGYAYWVCTTLQDKS

TTC37

931

Q6PGP7
DVVFGKYWLSQCFDA

UBASH3B

396

Q8TF42
ARNSCWSKDAEYGLY

TNFSF10

226

P50591
YLCFSSKDFTWVQNA

TLR5

696

O60602
PAEAWKVAYFYCLSN

ZFYVE26

316

Q68DK2
KGVDYASYYQGLWDC

SKAP1

291

Q86WV1
SWASCLQYDFDTQYA

WDFY1

156

Q8IWB7
TYAKNPNCKWYCYND

USP6

1331

P35125
TWYLKSADCYNEIYN

TMEM87A

81

Q8NBN3
ASCFSAKSVEQYYGW

YEATS2

1171

Q9ULM3
CGKVFSQNSYLAYHW

ZNF83

406

P51522
INCAYSNSASDYFIW

TRAV13-2

41

A0A0B4J235
WVNNCIGFSNYKFFL

ZDHHC15

161

Q96MV8
DYNECGTSFIWSSYL

ZNF606

401

Q8WXB4
GTLVAQCFSYSWFKA

XKR9

51

Q5GH70
SAYVWCVQGTNKVYF

ZAR1

341

Q86SH2
YNECGEAFLWTTYSN

ZNF283

656

Q8N7M2
GVDFACWCSYKYLNA

KYNU

266

Q16719